Form 8-K - Current report:
SEC Accession No. 0001640334-21-000821
Filing Date
2021-04-09
Accepted
2021-04-09 16:33:14
Documents
6
Period of Report
2021-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm 8-K 25232
2 EX-5.1 artl_ex51.htm EX-5.1 16326
3 EX-10.1 artl_ex101.htm EX-10.1 228444
4 artl_ex51img1.jpg GRAPHIC 3965
5 artl_ex51img2.jpg GRAPHIC 3854
6 artl_ex51img3.jpg GRAPHIC 3854
  Complete submission text file 0001640334-21-000821.txt   287838
Mailing Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037 760-943-1689
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 21818211
SIC: 2834 Pharmaceutical Preparations